| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 85849026 | FILING DATE | 02/13/2013 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | YARD, JOHN S |
L.O. ASSIGNED | 115 |
PUB INFORMATION |
|||
| RUN DATE | 03/29/2016 | ||
| PUB DATE | 05/14/2013 | ||
| STATUS | 819-SU - REGISTRATION REVIEW COMPLETE | ||
| STATUS DATE | 03/26/2016 | ||
| LITERAL MARK ELEMENT | FOTIVDA (TIVOZANIB HYDROCHLORIDE) | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | FOTIVDA (TIVOZANIB HYDROCHLORIDE) |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | YES |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | AVEO Pharmaceuticals, Inc. |
| ADDRESS | 1 Broadway, 14th Floor Cambridge, MA 02142 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for the treatment of cancer, namely, pharmaceutical preparations containing tivozanib hydrochloride |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 03/09/2016 | FIRST USE IN COMMERCE DATE | 03/09/2016 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | The color(s) blue, orange and yellow is/are claimed as a feature of the mark. |
| DISCLAIMER W/PREDETER TXT | "TIVOZANIB HYDROCHLORIDE" |
| DESCRIPTION OF MARK | The mark consists of the wording FOTIVDA (TIVOZANIB HYDROCHLORIDE) shown in blue, and the design of three overlapping curved vertical bands having pointed ends, with one band shown in shades of blue and orange, and the other two bands shown in shades in blue, orange and yellow. |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 03/29/2016 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 039 |
| 03/26/2016 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 038 |
| 03/25/2016 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 037 |
| 03/15/2016 | IUAF | S | USE AMENDMENT FILED | 036 |
| 03/15/2016 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 035 |
| 01/06/2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 034 |
| 01/05/2016 | EX5G | S | EXTENSION 5 GRANTED | 033 |
| 12/31/2015 | EXT5 | S | EXTENSION 5 FILED | 032 |
| 12/31/2015 | EEXT | I | TEAS EXTENSION RECEIVED | 031 |
| 07/21/2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 030 |
| 07/20/2015 | EX4G | S | EXTENSION 4 GRANTED | 029 |
| 07/02/2015 | EXT4 | S | EXTENSION 4 FILED | 028 |
| 07/06/2015 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 027 |
| 07/06/2015 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 026 |
| 07/02/2015 | EEXT | I | TEAS EXTENSION RECEIVED | 025 |
| 05/29/2015 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 024 |
| 05/29/2015 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 023 |
| 01/06/2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 022 |
| 01/05/2015 | EX3G | S | EXTENSION 3 GRANTED | 021 |
| 12/26/2014 | EXT3 | S | EXTENSION 3 FILED | 020 |
| 12/26/2014 | EEXT | I | TEAS EXTENSION RECEIVED | 019 |
| 05/01/2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 018 |
| 04/30/2014 | EX2G | S | EXTENSION 2 GRANTED | 017 |
| 04/10/2014 | EXT2 | S | EXTENSION 2 FILED | 016 |
| 04/30/2014 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 015 |
| 04/10/2014 | EEXT | I | TEAS EXTENSION RECEIVED | 014 |
| 01/08/2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 013 |
| 01/06/2014 | EX1G | S | EXTENSION 1 GRANTED | 012 |
| 01/06/2014 | EXT1 | S | EXTENSION 1 FILED | 011 |
| 01/06/2014 | EEXT | I | TEAS EXTENSION RECEIVED | 010 |
| 07/09/2013 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 009 |
| 05/14/2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 008 |
| 05/14/2013 | PUBO | A | PUBLISHED FOR OPPOSITION | 007 |
| 04/24/2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 006 |
| 04/08/2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 005 |
| 03/31/2013 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 02/22/2013 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 02/21/2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 02/16/2013 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Timothy H. Hiebert |
| CORRESPONDENCE ADDRESS | TIMOTHY H. HIEBERT SAMUELS & HIEBERT LLC 2 INTERNATIONAL PL FL 23 BOSTON, MA 02110-4106 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | AVEO Pharmaceuticals, Inc. |
| ADDRESS | 75 Sidney Street Cambridge, MA 02139 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |